Joined July 2025
- Tweets 494
- Following 3
- Followers 5
- Likes 3
79 Photos and videos
3 Dec 2025
Microba secures $3.06M R&D tax refund, boosting cash position to support gastrointestinal diagnostics and clinical therapeutics development @MicrobaLife $MAP
stockwirex.com/asx-stock-new…
45
3 Dec 2025
Phoslock Environmental Technologies resumes production at its China facility in January 2026 after four years, driven by depleted inventory @PhoslockWater $PET
stockwirex.com/asx-stock-new…
2
89
3 Dec 2025
Immuron secures US Department of Defense sub-award to develop oral therapeutics targeting military diarrhoea threats. @immuronltd $IMC
stockwirex.com/asx-stock-new…
147
3 Dec 2025
@MicroequitiesAM delivers $1.9M November profit as Pure Microcap Value Fund drives strong performance, pushing 1H26 YTD to $5.3M. $MAM
stockwirex.com/asx-stock-new…
11
3 Dec 2025
Kelly Partners climbs to 17th in AFR Top 100 Accounting Firms with $164.2M revenue run rate, now 82% of the way to cracking Top 10. $KPG
stockwirex.com/asx-stock-new…
197
3 Dec 2025
Mach7 secures first commercial Flamingo Architecture deployment with UnityPoint Health, generating A$0.6M ARR scaling to A$1.0M. $M7T
stockwirex.com/asx-stock-new…
30
3 Dec 2025
Avecho Biotechnology secures US and European patent allowances for its CBD TPM® soft-gel capsule, protecting the formulation until 2040. $AVE
stockwirex.com/asx-stock-new…
26
2 Dec 2025
4DMedical secures major distribution partnership with Philips, guaranteeing A$15M minimum revenue across 2026-2027 for FDA-cleared CT:VQ™ technology. $4DX
stockwirex.com/asx-stock-new…
1
43
2 Dec 2025
OncoSil's OSPREY registry shows 20.6-22.0 month survival in pancreatic cancer patients vs 12.7-18.8 months for chemotherapy alone. $OSL
stockwirex.com/asx-stock-new…
40
2 Dec 2025
LTR Pharma secures ethics approval for SPONTAN Phase II erectile dysfunction study, with patient recruitment starting Q1 2026 and initial data expected Q2 2026. $LTP
stockwirex.com/asx-stock-new…
45
2 Dec 2025
Microba scores $3.06M R&D tax refund, boosting cash to ~$17M and extending runway for GI diagnostics and therapeutics without diluting shareholders @MicrobaLife $MAP
stockwirex.com/asx-stock-new…
15
2 Dec 2025
Invion secures perpetual global rights to Photosoft™ technology across $96.4B cancer markets via milestone-based share issuance. @InvionLimited $IVX
stockwirex.com/asx-stock-new…
29
2 Dec 2025
Phoslock Environmental Technologies restarts manufacturing at its China facility in January 2026, with initial capacity of 3,000 tonnes annually. @PhoslockEnviro $PET
stockwirex.com/asx-stock-new…
2
264
2 Dec 2025
Control Bionics acquires remaining 77.83% of Neuro Elite Athletics for US$389k, bringing EMG sports performance tech fully in-house. @ControlBionics $CBL
stockwirex.com/asx-stock-new…
29
2 Dec 2025
Island Pharmaceuticals secures $1M from insiders including Chairman Jason Carroll for Galidesivir antiviral programme, boosting cash to $7.91M. $ILA
stockwirex.com/asx-stock-new…
34
2 Dec 2025
BetMakers renews Penn Entertainment contract for 3 years with improved terms, boosting EBITDA by A$1.2M annually while adding 16 new Apollo customers. $BET
stockwirex.com/asx-stock-new…
34
2 Dec 2025
Li-S Energy partners with UK defence contractor @MSubsLtd to test lithium-sulfur batteries for autonomous submarines, targeting Royal Navy programmes. $LIS
stockwirex.com/asx-stock-new…
25
2 Dec 2025
Amplia Therapeutics secures US patent grant for cancer drug narmafotinib, protecting its formulation until 2040 across major markets. $ATX
stockwirex.com/asx-stock-new…
1
64
2 Dec 2025
Optiscan Imaging launches pivotal head and neck cancer study at Perth hospital, with data set to support FDA submissions @OptiscanImaging $OIL
stockwirex.com/asx-stock-new…
39
2 Dec 2025
BCAL Diagnostics secures national ethics approval for landmark BREASTEST Registry, enrolling up to 24,000 women @BCALDxLtd $BDX
stockwirex.com/asx-stock-new…
1
34